Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is Belinostat.
| Product ID | 68152-108_8361737e-fcce-4a93-97ca-1220b1132979 | 
| NDC | 68152-108 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Beleodaq | 
| Generic Name | Belinostat | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2014-07-21 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206256 | 
| Labeler Name | Spectrum Pharmaceuticals, Inc. | 
| Substance Name | BELINOSTAT | 
| Active Ingredient Strength | 500 mg/10mL | 
| Pharm Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2014-07-21 | 
| Marketing End Date | 2022-11-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206256 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2014-07-21 | 
| Ingredient | Strength | 
|---|---|
| BELINOSTAT | 500 mg/10mL | 
| SPL SET ID: | 84b2e16e-f0d1-4757-8da8-79dfa83aab79 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 68152-108 | Beleodaq | Belinostat | 
| 69605-002 | Beleodaq | Belinostat | 
| 72893-002 | Beleodaq | Belinostat | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() BELEODAQ  86140026  4626277 Live/Registered  | 
        ACROTECH BIOPHARMA LLC  2013-12-10  |